%0 Journal Article
%T Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade
%A Howard L. Kaufman
%A Praveen K. Bommareddy
%A Samuel D. Rabkin
%J Archive of "Oncoimmunology".
%D 2019
%R 10.1080/2162402X.2019.1571390
%K Immunotherapy
%K MEK inhibition
%K Melanoma
%K Oncolytic virus
%K Programmed cell death 1 (PD-1)
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422399/